HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sabinsa Adds Patents To Thwart ‘Low Quality Copycats,’ Launches Liver Health Supplement

Executive Summary

Two patents in Mexico in past month for and three in Canada for compositions intended to slow inflammation and to strengthen hair growth.. It also recently launched LivLonga, a patented formulation to benefit liver health.

You may also be interested in...



Sabinsa Reaches Out To US Regulators To Squeeze Fake Vitamin C Out Of Ingredient Markets

Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”

Sabinsa’s Curcumin Complex Reduces Inflammation In Traumatic Brain Injury Patients

Iranian researchers found using 500 mg curcumin complex daily for seven days reduced levels of leptin, which can promote inflammatory response, in patients with traumatic brain injury. In study published in Phytotherapy Research, 28 subjects had an overall 47.1% reduction in leptin.

US Wellness Market Deals: Unilever Tries On SmartyPants, Kind Cooks Up Nature’s Bakery Deal

Unilever North America agrees SmartyPant, founded in 2011 to create a comprehensive supplement made from premium ingredients to support the wellbeing needs of children and adults. Kind, fully owned by Mars, has an agreement to acquire family-owned Nature's Bakery which offers snacks including fig bars and other soft-baked foods.

Topics

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel